Company / Share Buybacks
ImmunityBio, Inc. Share Buybacks History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$2.5M
FY2021
5-year range
$2.5M / $2.5M
FY2017-FY2021
Trend
-
vs FY2020
Sector context
#40 of 48
Health Care
What the data says
ImmunityBio, Inc.'s share buybacks of $3M is lower than 83% of companies in the Health Care sector (FY2021). Share Buybacks returned to growth in FY2021 after 2 years of decline, reaching $3M.
Based on SEC 10-K filings.
$3M in FY2021 with a 3-year CAGR of -46.0%.
Remained stable around $3M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -46.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 48This company $2.5M Sector average $611.9M
▼
-99.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -46.0%, indicating a declining trend.
- Ranks #40 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2018.
- Lowest share buybacks in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $2.5M | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $2.5M | -84.2% |
| FY2018 | $15.8M | +230.3% |
| FY2017 | $4.8M | - |
| FY2016 | $0 | -100.0% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026